Advanced Enzyme Technologies Limited (BOM:540025)

Market Cap	34.24B
Revenue (ttm)	7.07B
Net Income (ttm)	1.47B
Shares Out	n/a
EPS (ttm)	13.16
PE Ratio	23.23
Forward PE	20.32
Dividend	5.20 (1.66%)
Ex-Dividend Date	Jul 23, 2025

Volume	5,127
Average Volume	20,224
Open	311.20
Previous Close	313.25
Day's Range	311.00 - 314.85
52-Week Range	257.85 - 411.80
Beta	n/a
RSI	40.60
Earnings Date	Nov 12, 2025

About BOM:540025

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as...

• Industry: Industrial Organic Chemicals
• Founded: 1957
• Employees: 338
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540025

Financial Performance

In 2024, BOM:540025's revenue was 6.37 billion, an increase of 2.09% compared to the previous year's 6.24 billion. Earnings were 1.31 billion, a decrease of -1.64%.